Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differential regulation of E2F transactivation by cyclin/cdk2 complexes

B D Dynlacht1, O Flores, J A Lees

  • 1Massachusetts General Hospital Cancer Center, Charlestown 02129.

Genes & Development
|August 1, 1994
PubMed
Summary

The tumor suppressor protein pRB represses E2F transcription, but this is reversed by phosphorylation. Cyclin A/cdk2 inactivates E2F by phosphorylation, linking cell cycle kinases to transcription regulation.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Python-based flow solver for numerical simulations using an immersed boundary method on single GPUs.

Computers & fluids·2026
Same author

Intracerebroventricular phospho-tau immunotherapy alleviates cortical phospho-tau burden and motor phenotype in a neuron-specific P301S tauopathy mouse.

Experimental neurology·2025
Same author

Hemodynamics affects factor XI/XII anticoagulation efficacy in patient-derived left atrial models.

Computer methods and programs in biomedicine·2025
Same author

The feasibility of masks and face shields designed by 3D printing makers; some considerations of their use against the COVID-19.

Materials today. Proceedings·2022
Same author

LncRNA RP11-19E11 is an E2F1 target required for proliferation and survival of basal breast cancer.

NPJ breast cancer·2020
Same author

Randomised clinical trial: a leucine-metformin-sildenafil combination (NS-0200) vs placebo in patients with non-alcoholic fatty liver disease.

Alimentary pharmacology & therapeutics·2018

Area of Science:

  • Molecular Biology
  • Cell Cycle Regulation
  • Cancer Biology

Background:

  • The transcription factor E2F is crucial for cell proliferation gene expression.
  • Understanding E2F regulation is key to controlling cellular growth.

Purpose of the Study:

  • To investigate the regulation of the transcription factor E2F.
  • To characterize the interaction between E2F, pRB, and cyclin-dependent kinases (CDKs).

Main Methods:

  • Development of a reconstituted in vitro transcription assay.
  • Utilizing the E2F-responsive assay to study transcriptional regulation.

Main Results:

  • The tumor suppressor protein pRB directly represses E2F-mediated transcription.

Related Experiment Videos

  • Phosphorylation of pRB by cyclin A/cdk2 or cyclin E/cdk2 abolishes E2F repression.
  • Cyclin A/cdk2 effectively phosphorylates E2F, inhibiting its DNA binding and trans-activation ability.

    • Conclusions:

    • The developed in vitro assay enables activation and inactivation of E2F transcription.
    • Transcriptional regulation of E2F is linked to cell cycle-dependent kinase activation.
    • Findings elucidate a mechanism for controlling cell proliferation through E2F and pRB modulation by CDKs.